AMT vs. NVS

In the year-to-date period, AMT achieves a -6.75% return, which is significantly lower than NVS's 5.66% return. Over the past 10 years, AMT has outperformed NVS with an annualized return of 9.37%, while NVS has yielded a comparatively lower 6.67% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for American Tower Corporation (AMT) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current AMT Sharpe Ratio is 0.15, which is lower than the NVS Sharpe Ratio of 0.81. The chart below compares the historical Sharpe Ratios of AMT and NVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

AMT's dividend yield for the trailing twelve months is around 3.34%, less than NVS's 3.68% yield.

The maximum AMT drawdown since its inception was -98.70%, which is greater than NVS's maximum drawdown of -41.72%. Use the drawdown chart below to compare losses from any high point for AMT and NVS. For additional features, visit the drawdowns tool.

American Tower Corporation (AMT) has a higher volatility of 10.28% compared to Novartis AG (NVS) at 5.85%. This indicates that AMT's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between American Tower Corporation and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.